Q4 2017 13F Holders as of 31 Dec 2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
245
-
Total 13F shares, excl. options
-
51,414,850
-
Shares change
-
+827,842
-
Total reported value, excl. options
-
$3,496,341,436
-
Value change
-
+$19,380,879
-
Put/Call ratio
-
39%
-
Number of buys
-
115
-
Number of sells
-
128
-
Price
-
$68.00
Institutional Holders of CLOVIS ONCOLOGY INC - COM (CLVSQ) as of Q4 2017
As of 31 Dec 2017 CLOVIS ONCOLOGY INC - COM (CLVSQ) had 245 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 51,414,850 shares of stock of the company.
Largest 10 holders included Vanguard Group Inc, BlackRock Inc., Palo Alto Investors, LLC, PointState Capital LP, FRANKLIN RESOURCES INC, FMR LLC, ORBIMED ADVISORS LLC, STATE STREET CORP, Carmignac Gestion, and Redmile Group, LLC.
This table shows 245 institutional shareholders of the security as of 31 Dec 2017.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.